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Abstract
Copy-number variants (CNVs) reshape gene structure, modulate gene expression, and contribute to signiﬁcant phenotypic
variation. Previous studies have revealed CNV patterns in natural populations of Drosophila melanogaster and suggested that
selection and mutational bias shape genomic patterns of CNV. Although previous CNV studies focused on heterogeneous
strains, here, we established a number of second-chromosome substitution lines to uncover CNV characteristics when
homozygous. The percentage of genes harboring CNVs is higher than found in previous studies. More CNVs are detected in
homozygous than heterozygous substitution strains, suggesting the comparative genomic hybridization arrays un-
derestimate CNV owing to heterozygous masking. We incorporated previous gene expression data collected from some of
the same substitution lines to investigate relationships between CNV gene dosage and expression. Most genes present in
CNVs show no evidence of increased or diminished transcription, and the fraction of such dosage-insensitive CNVs is greater
in heterozygotes. More than 70% of the dosage-sensitive CNVs are recessive with undetectable effects on transcription in
heterozygotes. A deﬁciency of singletons in recessive dosage-sensitive CNVs supports the hypothesis that most CNVs are
subject to negative selection. On the other hand, relaxed purifying selection might account for the higher number of
protein–protein interactions in dosage-insensitive CNVs than in dosage-sensitive CNVs. Dosage-sensitive CNVs that are
upregulated and downregulated coincide with copy-number increases and decreases. Our results help clarify the relation
between CNV dosage and gene expression in the D. melanogaster genome.
Key words: copy-number variation, gene expression, gene dosage sensitivity, recessive CNV, selection.
Introduction
Recent analyses of structural genetic variation have high-
lighted the presence of extensive naturally occurring
copy-number variants (CNVs) in organisms as diverse as hu-
mans,fruitﬂies,yeast,andplants(Sebatetal.2004;Snijders
et al. 2005; Perry et al. 2006; Redon et al. 2006; Dopman
and Hartl 2007; Emerson et al. 2008; McCarroll et al. 2008;
Carretoetal.2008;DeBolt2010).About10%ofthehuman
genomeharborCNVs(Redonetal.2006),withanestimated
average of 12 CNVs per individual relative to a reference se-
quence (Feuk et al. 2006). In humans, a number of studies
have indicated links between CNV and disease phenotypes
(McCarroll and Altshuler 2007; Zhang et al. 2009; WTCCC
2010), whereas only a handful of studies have been con-
ducted in natural populations of Drosophila melanogaster.
Similar to estimates from the human genome, about
5–8% of the D. melanogaster genome were estimated to
contain CNVs (Dopman and Hartl 2007; Emerson et al.
2008; Cridland and Thornton 2010). The nonrandom distri-
bution CNV patterns in D. melanogaster suggest that selec-
tion and mutational biases are primary forces that shape
structural variation (Dopman and Hartl 2007; Emerson
et al. 2008). Furthermore, the occurrence of CNVs was
found to be negatively associated with the abundance of
protein–protein interactions (Dopman and Hartl 2007). To
date, all the reported CNVanalyses in D. melanogaster were
based on heterogeneous isofemale strains from natural
populations. Many CNVs are presumably heterozygous in
these lines, which is problematic because the incidence of
CNVs may be underestimated. Hence, a better resolution
of CNVs may be expected from studies of homozygous
genotypes.
This paper forms part of a Special Collection on Chance and Necessity in Evolution
from a meeting in Ravello, Italy, October 2010
ª The Author(s) 2011. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/
3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
1014 Genome Biol. Evol. 3:1014–1024. doi:10.1093/gbe/evr023
GBEIn the human genome, about half of the CNVs detected
overlap with protein-coding regions (Sebat et al. 2004)
changing gene structure and dosage. Therefore, CNV loci
encompassing genes may potentially affect gene expres-
sion, which can subsequently shape ecologically, evolution-
arily, and medically relevant phenotypes (Stranger et al.
2007; Henrichsen et al. 2009; Schuster-Bo ¨ckler et al. 2010).
Compensatory mechanisms are commonly invoked in at-
tempts to understand the functional and evolutionary con-
sequences of ploidy and sex determination (Birchler et al.
2007; Vicoso and Bachtrog 2009), but dosage must also
be important for CNV loci encompassing individual genes.
Indeed, disruption in the stoichiometric balance of proteins
belonging to molecular complexes may affect gene expres-
sion (Birchler et al. 2005). The effects of aneuploidy result
from a change in the relative dosage balance among various
regulatory components that arise due to unbalanced alter-
ations in gene copy number (Birchler et al. 2001, 2005).
Dosage sensitivity is an essential evolutionary mechanism
that inﬂuences gene dispensability. Although the underlying
causes of dosage sensitivity remain poorly understood, pre-
vious reports suggested a complex relationship between
haploinsufﬁciency and duplication sensitivity (Veitia 2002).
Complexity may be explained from the balance hypothesis
(Birchler et al. 2007) in which multiprotein complexes need
to maintain the stoichiometry of their subunits to perform
biological functions (Papp et al. 2003). As CNVs harboring
duplications and deletions potentially create gene dosage
effects, understanding the balance between CNV gene dos-
age and expression should shed light on the evolution of
CNVs and how CNVs affect gene regulation.
It was previously reported that more than 70% of genes
in D. melanogaster that are differentially expressed in con-
trasts between homozygous genotypes lack expression dif-
ferences when in the heterozygous state (Lemos et al.
2008). This result suggested that recessive alleles with reg-
ulatory consequences might be abundant in Drosophila
(Lemos et al. 2008). Because gene heterozygosity is preva-
lent in natural populations (Singh and Rhomberg 1987), the
expression of genes encompassed in CNV could also be
largely masked in heterozygotes.
Here,we addressed the relevance of CNV in homozygous
and heterozygous genotypes to reveal dosage effects of
CNVs. We generated six second-chromosome substitution
homozygous lines and two heterozygous lines to investigate
CNV patterns. We also utilized gene expression data con-
ducted with some of the same substitution lines to infer
the association between CNVs and their gene expression.
We found that most CNVs appear to have low levels of dos-
age sensitivity, and they are often recessive in heterozygous
state. Nevertheless, increases and decreases in copy number
coincide with up- and downregulation in a number of cases.
Overall, our work highlights complex relationships between
gene dosage and expression.
Materials and Methods
Fly Stocks
Some of the second-chromosome substitution strains (PS1,
PS2, PS3, CS) in this study were previously described by
Lemos et al. (2008). Strains PS4 and PS5 were established
using identical methodology (supplementary ﬁg. S1 in
Lemos et al. 2008). Heterozygous strains PS2/CS and PS5/
CS are obtained in the F1 generation of homozygous sec-
ond-chromosome substitution strains and contain two dif-
ferent second chromosomes in an otherwise identical
genetic background. A total of eight strains were assayed.
DNA Isolation and Digestion
Genomic DNA was isolated from either 40 adult females or
60 males, using QIAGEN DNeasy blood and tissue kit (Cat.
No. 695004). Genomic DNA was then digested with 1.5 ll
MspI enzyme to randomly digest the genome into moder-
ately sized fragments (average size ; 3.5 kb, Barker
et al. 1984). Restriction digests followed the manufacture’s
recommendations (New England BioLabs, 20,000 U/ml) of
37  C for 1 h; an equal amount of enzyme was added
for an additional 1 h to assure complete digestion. DNA
was furthercleaned byPhaseLockGel (Eppendorf)andphe-
nol puriﬁcation. Five micrograms DNA was used for each
sample resulting in 10 lg DNA in each microarray reaction.
Microarray Platform
Arraycomparativegenomichybridizations(aCGH)wereper-
formed with an 18,000-feature DNA microarray. Labeling
and hybridization were conducted with the 3DNA Array
900 MPX kit (Genisphere), with a Cy5–Cy3 two-channel
dye swap for each reaction. All the DNA copy-number
increases and decreases in the other seven sampled strains
were estimated relative to PS1. Besides the dye swap, every
reaction had at least two replicates (experimental design
shown in supplementary ﬁg. S1, Supplementary Material
online). Upon hybridization, microarray slides were scanned
in anAxon4000Bscanner(AxonInstruments). Gene expres-
sion microarrays, experimental designs, and previous results
used in this study were obtained from Lemos et al. (2008).
Microarray Analyses
Scanned microarray slides were ﬁrst analyzed with GenePix
Pro 6.0 software (Axon Instruments). Fluorescence Cy5 and
Cy3intensitieswerethennormalizedbytheLimmalibraryof
software R (Version 2.10.1). Two different methods were
used to ascertain copy-number increases and decreases:
threshold analysis and Bayesian Analysis of Gene Expression
Levels (BAGEL). In threshold analysis, probes were sug-
gested as indicating an occurrence of a CNV event if the
standard error of the log-intensity ratio was beyond an in-
tensity-ratio threshold. The threshold ratio was established
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trolling the false-positives to ,1% (for more details, see
Dopman and Hartl 2007). BAGEL analysis uses Bayesian al-
gorithm to compute the probe signal ratios between sam-
ples and the reference strain, with P values indicating the
signiﬁcance (for more details, see Townsend and Hartl
2002; Lemos et al. 2008). Array probes located in transpo-
sons or containing repetitive sequences were removed from
theanalyses.Thetwomethodswereingoodagreementand
the patterns herein described are robust to the choice of
methodforascertaininggainsandlosses.Onlythethreshold
results are shown in great detail in the Results.
Analyses Schemes for Associations between CNVs
and Gene Expression
To determine dosage effects of CNVs in homozygotes, ‘‘hor-
izontal’’ comparisons of gene expression levels between ho-
mozygous PS2 and PS1 were conducted as illustrated in
ﬁgure 2. To determine dosage effects of CNVs in heterozy-
gotes, horizontal comparisons of gene expression levels be-
tween heterozygous PS1/PS3 and PS2/PS3 were conducted.
Todetermine recessive CNVs (heterozygousmaskingeffect),
theresultscollectedfromhomozygousPS2andPS1compar-
isons were combined with those for PS1/PS3 and PS2/PS3
heterozygotes to infer if the same CNV genes in PS2 are
recessive to PS3. To determine if upregulated or downregu-
lated CNVs are matched with copy-number increases or de-
creases, ‘‘vertical’’ comparisons between PS1/PS1 and PS1/
PS3 were conducted as also shown in ﬁgure 2, where in this
comparison, PS3 harbors CNVs relative to PS1 instead of no
differences from PS1 in the horizontal comparisons.
Protein Interactions for CNV Genes
The interaction data set from BIOGRID (Stark et al. 2006;
http://thebiogrid.org/) was used to detect protein–protein
interactions for dosage-sensitive, dosage-insensitive, reces-
sive and nonrecessive CNV genes in different context. Only
genes with 1 interactions were analyzed.
Results
Populations of D. melanogaster can be polymorphic for as
many as 43% of their gene loci, and an average individual
typically shows a level of heterozygosity on the order of
10% (Singh and Rhomberg 1987). Several recent studies
have accessed CNVs with microarray and sequencing tech-
nologies using genetically heterogeneous isofemale strains
(DopmanandHartl2007;Emersonetal.2008;Cridlandand
Thornton 2010). However,the contribution ofcopy-number
heterozygosity to estimates of copy-number variation is dif-
ﬁcult to evaluate. Therefore, we investigated CNVs in com-
pletely homozygous chromosome substitution lines, which
differ exclusively in the origin of the second chromosome
but are otherwise genetically identical. All the second chro-
mosomes were derived from a single Pennsylvania popula-
tion (except line CS), whereas other chromosomes were
originated from the marker lines used to construct these
substitution lines (for details, see supplementary ﬁg. S1 in
Lemos et al. 2008). These second-chromosome substitution
strains offer two major advantages. First, false positive error
rates can be experimentally ascertained because no CNVs
are expected to be found from probes located in the third,
fourth, and X chromosomes. Second, chromosomes are ho-
mozygous within each strain, and so issues of detection as-
sociated with identifying CNVs in heterozygotes can be
avoided. In this study, we utilized six homozygous and
two heterozygous second-chromosome substitution lines,
originally established by Lemos et al. (2008), to reveal the
CNV patterns.
Variation in gene expression levels contributes to dra-
matic phenotypic differences between individuals and pop-
ulations. Gene copy-number differences among individuals
and populations can provide a source of gene expression
variation (Stranger et al. 2007), although evidence suggests
complex relationships between gene copy number and ex-
pression (Birchler et al. 2005, 2007). Changes in dosage of
individual chromosome or chromosomal segments have
more extreme global effects on gene expression than ob-
served in ploidy series (Birchler et al. 2007). The balance be-
tween CNV gene dosage and expression levels can address
how signiﬁcant gene copy variation as well as gene struc-
tural changes induced by CNVs may affect gene regulation.
Here, we addressed the extent of copy-number variation
across chromosomes sampled from a single population (ex-
cept for strain CS) and also combined this CNV data with
previously reported gene expression data (Lemos et al.
2008) to investigate the balance between gene dosage
and expression.
Validation of Methods Used in the Detection of
CNVs
As females have two copies of X-linked genes and males
only have one copy, male–female aCGH result in an excess
of female signals for X-linked genes that can be used to cal-
ibrate the threshold values and detection methods. Indeed,
lower signal ratios betweenmale and female X-linked genes
are reﬂected in supplementary ﬁgure S2A (Supplementary
Material online) (based on threshold analysis; data on
a log scale). In addition, only the second chromosomes in
the substitution lines may be expected to contain gene
copy-number variation, as all other chromosomes are in
principle invariantacross all strains.Indeed,asshownin sup-
plementary ﬁgure S2B (Supplementary Material online), in
one of the substitution strains (PS2) relative to the reference
strain PS1, the second chromosome contains virtually all of
the CNVs detected by microarray hybridizations. Other
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shown). With regard to BAGEL analyses, supplementary
ﬁgure S3 (Supplementary Material online) demonstrates
the distributions of probabilities of CNV occurrence in the
sample strain PS2 compared with the reference strain
PS1. As expected, the distribution of P values for probes lo-
cated in the second chromosome is notably skewed to low
(P , 0.05) or high (P . 0.95), indicating copy-number
decrease and increase in PS2, respectively. In contrast, and
in agreement with the expectation if the third, fourth,
and X chromosomes are invariant, the distribution of P val-
ues is uniform for pooled data from all other chromosomes.
These observations suggest a substantial level of variation of
gene copy numbers on the second chromosome that can be
detectedwithtwodistinctmethods.Inthefollowing,weon-
ly showresultsandanalyses based on the threshold method.
CNVs in Homozygous Second-Chromosome Sub-
stitution Strains
The number and fractions of CNV increases and decreases
in ﬁve homozygous and two heterozygous second-
chromosome substitution strains, relative to the reference
strain, are plotted in ﬁgure 1. Because sample arrays and
their replicates were not all prepared at the same time,
batch variation may result in different detection rates of
aCGH. The number of CNV increases between a sample
strain and PS1 ranged from ;100 to 350 and the number
of CNV decreases ranged from ;100 to 400 depending
on the batch and strain. However, the fraction of CNVs that
increased ordecreased in number was found to be balanced
in each strain (ﬁg. 1A). In some of the strains, such as PS2,
PS3,CS, andHeterozygous PS5/CS, therewere slightly more
copy-number decreases (on average 5%) than increases. In
PS5, more increases (5%) were observed. The fractions
were within 0.5% variation in PS4 and PS2/CS.
The percentages of probes containing CNVs among all
the detected genes on the second chromosomes are shown
on top of the bars in ﬁgure 1A. For the ﬁve homozygous
strains, the average CNV fraction is about 9.5% (range from
7.7% to 14.4%), a ﬁnding that is somewhat higher than
previous reports of 5–8% in D. melanogaster (Dopman
andHartl2007;Emersonetal.2008;Cridland andThornton
2010). The levels of variation detected in heterozygous PS2/
CS (5.7%) and PS5/CS (6.1%) were lower than in their ho-
mozygotes.Twofactorscanaccountfortheselowerpercen-
tages in heterozygotes. First, some duplications and
deletions may complement each other in heterozygotes re-
sulting in no variation compared with the reference strain.
Second, and most likely in view of the observation that most
CNVs are singletons(discussedin the followingparagraphs),
aCGHarraysmaybelesssensitivetodetectingcopy-number
variation in heterozygotes. This is because whenever a CNV
is unique to only one homozygous strain, the magnitude of
fold-change between the homozygous reference strain and
the heterozyogous is less extreme.
CNVs can be either clustered at certain regions or dis-
persed across a whole chromosome. To distinguish CNVs
from larger scale segmental duplications, we investigated
CNV clustering by checking the fraction of CNVs that can
be found in contiguous sets of more than three CNVs along
the second chromosome. Minor clustering was found (sup-
plementary table S1, Supplementary Material online). None
of those clustered area involved more than six genes. In-
stead, CNVs were spread across the whole second chromo-
somes.
CNV Allele Frequency
All CNVs present in the ﬁve homozygous strains were as-
sessed for their allele frequencies. All copy-number in-
creases and decreases were evaluated relative to PS1.
Therefore, we did not know if a detected copy-number
FIG. 1.—CNV composition in homozygous second chromosomes.
(A) Summary of CNV copy-number increases and decreases relative to
a reference strain PS1 in the seven second-chromosome substitution
lines, homozygous PS2, PS3, CS, PS4, and PS5; heterozygous PS2/CS
and PS5/CS. Bars represent the fractions of CNV increases (gray) and
decreases (black). The numbers on top of the bars show the number of
increases and decreases detected in each strain, respectively. The
percentages on top of the numbers indicate the percentage of genes
(probes) containing CNVs among all the detected genes (probes) from
the second chromosomes. (B) A pie chart demonstrating the fraction of
singleton and nonsingleton CNVs derived from the ﬁve homozygous
lines (CNV allele frequencies) relative to PS1. The black area shows the
fraction of singletons that contain decreased copies in one strain relative
to the other four strains and the reference strain PS1. The gray area
shows the fraction of singletons that contain increased copies in only
one strain. The white area shows the fraction of nonsingletons that
appear in more than one strain as either increase or decrease.
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We make theparsimonious assumption thatthe minor allele
(lower frequency) represents the derived state. For example,
a focal probe showing higher copy number across all
ﬁve ‘‘test’’ strains is most parsimoniously interpreted as
a copy-number reduction in PS1. As shown in ﬁgure 1B,
37.6% of the copy-number increases as well as 42.2% of
the decreases were unique to a single strain (singleton).
The singletons discovered in only one strain are more likely
to be true deletions and duplications relative to all other
ﬁve strains including reference strain PS1, otherwise one
would need to posit a shared CNV in other ﬁve strains.
The nonsingleton 20.2% of CNVs were detected more than
once among the ﬁve strains, among which 7.7% shared
copy-number increase only relative to PS1, 7.3% shared
copy-number decrease only, and 5.2% showed either in-
crease or decrease in different strains. The fractions of sin-
gleton and nonsingleton between copy-number increase
and decrease are not signiﬁcantly different (Fisher’s exact
test, P 5 0.193).
Dosage Effects of CNVs on Expression in Homo-
zygotes
The majority of the array probes used in this study are lo-
cated in gene regions. In total, 11,934 genes are repre-
sented on the array with an average of 1.2 probes per
gene (Hild et al. 2003; Dopman and Hartl 2007). Therefore,
the same array platform can be used to compare gene copy
number and expression variation. How gene expression lev-
els and CNVs correlate with each other is essential to under-
standing how structural changes induced by CNVs affect
gene regulation.
We began by investigating CNVs and their expression
levels in homozygous PS2 and homozygous PS1. Shown
in ﬁgure 2, if a gene in homozygous PS2 showed both
an increase in copy number and expression level relative
to that of the homozygous reference strain PS1, this focal
gene is termed ‘‘dosage sensitive.’’ A gene in PS2 that
showed both a decrease in copy number and expression rel-
ative to the reference is likewise termed dosage sensitive.
Conversely, a gene showing an increase in copy number
but a lower expression level than the reference is termed
‘‘dosage reversed.’’ Genes whose expression levels do not
change despite alterations in copy number are termed ‘‘dos-
age insensitive.’’ We observed that 21% of CNVs had
matching expression variation, with 27 and 17 CNVs in
PS2 showing dosage-sensitive and dosage-reversed expres-
sion phenotypes, respectively. On the other hand, 163 CNVs
(79%) showed no corresponding expression variation (dos-
age insensitive) in the homozygous–homozygous compari-
son between PS1 and PS2 (ﬁg. 3A). The dosage effects for
gene copy-number increases and decreases on gene expres-
sion levels were similar, as shown in ﬁgure 3B. Overall, 14.6%
and 11.5% CNVs were dosage sensitive for copy-number in-
creases and decreases, respectively; 9.7% and 6.7% CNVs
were dosage reversed for increases and decreases, respec-
tively; and 75.7% and 81.7% CNVs were dosage insensitive
for increases and decreases, respectively. There was no signif-
icant difference between CNV increase and decrease (Fisher
exact test, P 5 0.553). The largest fraction of CNVs fell into
the dosage-insensitive categories, which is examined further
in the Discussion. More importantly, the absolute expression
levels for dosage-sensitive genes did not differ from that of
dosage-insensitive genes. Two dosage-sensitive CNV genes
are shown in ﬁgure 4, in which both gene Cyp6g1 and
CG31636 had copy-number increases and higher expression
levels in PS2 relative to PS1. A dosage-reversed gene
CG15649 is also shown which had a higher copy number
but lower expression level in PS2 compared with PS1.
CNVs are Largely Recessive (Masked) in Hetero-
zygotes
Arechanges in copy number resulting in expression changes
in homozygous state recessive in heterozygotes? To address
this issue, we considered CNVs in PS2 homozygotes with the
expression phenotype manifested in the comparison be-
tween homozygous PS1 versus PS2 and investigated if such
expression differences were still present when heterozygous
PS2/PS3were contrastedwith heterozygous PS1/PS3. Forex-
ample, for a gene with both increased copy number and
higher expression in homozygous PS2 relative to homozy-
gous PS1 (ﬁg. 2, dosage sensitive in homozygotes), the
CNV is recessive if PS2/PS3 shows no expression difference
from PS1/PS3 heterozygotes. In contrast, the CNV is nonre-
cessive if a difference in expression observed in the homozy-
gotes is maintained in the contrast between PS2/PS3 and
PS1/PS3. One possible causeof the recessivity could be back-
groundtrans-factorsfromPS3.Nevertheless,theobservation
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FIG. 2.—Diagrams of analyses on associations of CNVs and gene
expression. PS1, PS2 and PS3 are three second-chromosome substitution
strains. The horizontal solid lines represent CNV alleles in each strain.
The left panel shows a ‘‘horizontal’’ comparison between PS1/PS1 and
PS2/PS2 homozygotes as well as between PS1/PS3 and PS2/PS3
heterozygotes, where PS2 contains CNVs relative to PS1 but PS3 allele
is the same as PS1. The right panel shows a ‘‘vertical’’ comparison
between PS1/PS1 and PS1/PS3, where PS3 allele harbors CNVs.
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heterozygous background.
We observed 19 (70%) recessive CNVs and 8 (30%) non-
recessive CNVs. Conversely, only 3% (5 of 163) of all dos-
age-insensitive CNVs that did not show expression
differences in the homozygous PS2 versus PS1 contrast ap-
peared to show expression differences in the heterozygous
PS2/PS3 versus PS1/PS3. There were 17 dosage-reversed
CNVs in the homozygous PS2 versus PS1 comparison,
76% of which were recessive in the heterozygous PS2/
PS3 versus PS1/PS3 contrast (ﬁg. 5A). The absolute expres-
sion levels for recessive genes did not differ from that of
nonrecessive genes (P 5 0.10, Mann–Whitney test). In both
of the dosage-sensitive and dosage-reversed groups, there
were more recessive CNVs than nonrecessive CNVs. As to
the dosage-insensitive CNVs, three CNVs harboring higher
copy number showed no expression difference in homozy-
gotes but higher levels in heterozygotes, and the other two
CNVs harboring lower copy number showed lower levels in
heterozygotes. The overall result suggests that expression
differences caused by gene copy-number changes are
largely masked in heterozygotes. Examples of nonrecessive
and recessive CNV genes are shown in the right panel of
ﬁgure 4. Gene Cyp6g1 appears to have a copy-number in-
crease and higherexpression level in PS2/PS3 relativeto PS1/
PS3 heterozygotes. In contrast, gene CG31636 has a higher
copy number but its expression level in PS2/PS3 does not
differ from PS1/PS3, therefore appears recessive.
For the recessive and nonrecessive CNVs identiﬁed in ho-
mozygous PS2 that were already categorized into dosage-
sensitive, -insensitive, and -reversed groups, the CNVs
were investigated for their allele frequencies (singleton or
nonsingleton). Because both dosage-sensitive and dosage-
reversed CNVs respond to copy-number changes, they were
grouped together to compare with the overall allele fre-
quency derived from all ﬁve homozygous strains. The group
of dosage-insensitive CNVs corresponds to ‘‘recessive’’ in
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FIG.4 . —Examples illustrating dosage sensitivity of CNV genes.
Expression indicates normalized estimates from BAGEL analysis. For all
panels, copy number is higher in PS2 than in PS1. Diamonds represent
genes, with credible intervals shown. The expression levels are normalized.
(A) Dosage-sensitive gene Cyp6g1 shows a copy-number increase and
higher expression level in PS2 relative to PS1. Its expression level is also
higher in PS2/PS3 heterozygotes compared with PS1/PS3, suggesting
nonrecessive phenotype of Cyp6g1 CNV gene. (B) Dosage-sensitive gene
CG31636 shows a copy-number increase and higher expression level in
PS2 relative to PS1. Its expression level is not different between PS2/PS3
and PS1/PS3 heterozygotes, suggesting recessive phenotype of CG31636
CNV gene. (C) Dosage-reversed gene CG15649 shows a copy-number
increase but lower expression level in PS2 relative to PS1.
FIG.3 . —Dosage effects of CNVs on expression in homozygotes. (A) In the left column, dosage sensitive indicates that CNVs have either copy-
number increases with higher expression levels than reference strain PS1 or else that copy-number decreases with lower expression levels than PS1. In
the right column, dosage reversed suggests opposite negative associations. The middle panel shows the number of CNVs that are not sensitive to copy-
number dosage effects. (B) The bars indicate the fractions of dosage-sensitive (gray), dosage-insensitive (black) and dosage-reversed CNVs (white) for
copy-number increases and decreases separately.
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PS3. Shown in ﬁgure 5B, the fraction of nonsingleton CNVs
is signiﬁcantly increased (Fisher exact test, P , 0.001) for
both recessive dosage-sensitive CNVs and dosage-insensi-
tive CNVs. However, we did not observe a signiﬁcant differ-
ence (Fisher exact test, P 5 0.137) for the fraction of
singletons and nonsingletons between nonrecessive dos-
age-sensitive CNVs and overall CNVs.
Dosage Effects of CNVs on Expression in Hetero-
zygotes
We also reconstructed heterozygous CNVs to directly corre-
late heterozygous gene expression levels in PS2/PS3 and
PS2/CS heterozygotes. In particular, for genes with variable
copy number between homozygous PS2 and PS1, we asked
what happens to the expression of genes in the heterozy-
gous state. This analysis differs from determining recessive
CNVs classiﬁed as dosage sensitive, dosage insensitive, or
dosage reversed in homozygous PS2. Gene expression
may change in the heterozygous background. In this anal-
ysis, horizontal comparisons (shown in ﬁg. 2) of gene ex-
pression levels between heterozygous PS1/PS3 and PS2/
PS3 (as well as PS1/CS and PS2/CS) were directly conducted
and the CNVs classiﬁed in regard to dosage sensitivity in the
heterozygous background. A total of 415 CNVs were
pooled from PS2/PS3 and PS2/CS heterozygotes in contrast
to PS1/PS3. Thirty-six CNVs showed dosage-sensitive
effects, whereas 11 showed dosage-reversed effects. The
remaining CNVs were dosage insensitive. Nearly 90% of
the total CNVs fell into the dosage-insensitive group. The
number of CNV increases and decreases is plotted sepa-
rately for three groups in ﬁgure 6A, along with their corre-
sponding fractions shown in ﬁgure 6B. The fractions show
no signiﬁcant differences (chi-square test, P 5 0.989).
Protein Interactions for CNV Genes
Dopman and Hartl (2007) reported that the occurrence of
CNV is negatively correlated with the degree of protein in-
teraction network. Natural selection plays critical roles in
shaping CNV patterns, and dosage-sensitive CNVs might
be expected to have greater functional consequences and
fewer protein–protein interactions than dosage-insensitive
ones.Asshowninﬁgure7A,the dosage-sensitiveCNVshave
a signiﬁcantly lower number of protein–protein interactions
than that of dosage-insensitive CNVs (dosage sensitive: one
proteininteractions[median];dosageinsensitive:twoprotein
interactions [median]; P 5 0.04, Mann–Whitney test). The
same pattern holds true for another measure of centrality:
betweenness (dosage sensitive, betweenness 5 0[ m e d i a n ] ;
dosageinsensitive,betweenness51002[median];P50.02,
Mann–Whitney test).
Similarly, one would expect to see a higher number of
interactions in recessive CNVs than that of nonrecessive
CNVs. Although the trend showed the prediction, the dif-
ference was not signiﬁcant (recessive: two protein interac-
tions [median]; nonrecessive: one protein interactions
[median]; P 5 0.22, Mann–Whitney test), possibly due to
the relatively smaller sample size (ﬁg. 7B). The same pattern
FIG. 5.—Reconstruction of recessive and nonrecessive CNVs. (A) Three groups of CNVs (dosage sensitive, dosage insensitive and dosage reversed)
from homozygous PS2 were investigated for their expression in heterozygous PS2/PS3 (for details, see Results). The numbers of recessive (black bars)
and nonrecessive (gray bars) CNVs in dosage-sensitive, -insensitive and -reversed CNVs of homozygous PS2 are plotted, respectively. Percentages of
recessive and nonrecessive CNVs are shown on the top. (B) Fractions of singleton and nonsingleton CNVs in the above groups of CNVs. Both dosage-
sensitive and -reversed CNVs respond to copy-number change such that they are grouped together in comparison with the overall allele frequency
derived from all ﬁve homozygous strains. Black bars indicate singleton CNVs. Gray bars indicate nonsingleton CNVs. Overall indicates singleton and
nonsingleton data collected from ﬁve homozygous strains. Asterisks indicate P , 0.001 in the comparison between either dosage sensitive (recessive) or
dosage insensitive and overall.
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(recessive, betweenness 5 311 [median]; nonrecessive, be-
tweenness 5 0 [median]; P 5 0.34, Mann–Whitney test].
Upregulation and Downregulation in CNVs
To infer if upregulated or downregulated CNVs match with
their copy-number changes, we employed a slightly differ-
ent analysis. As illustrated in ﬁgure 2, PS1/PS1 and PS1/PS3
(or PS1/CS) were vertically compared in which PS3 (or CS)
contained CNVs. A number of CNVs involving upregulation
and downregulation were detected. These CNVs were then
sorted based upon copy-number increases or decreases.
Shown in ﬁgure 8, 17 CNVs containing copy-number
increases in PS3 and CS were upregulated (higher copy
number and higher expression) relative to PS1 in heterozy-
gous PS1/PS3 or PS1/CS, whereas only two CNVs with
increases were downregulated (lower expression). In con-
trast, more downregulation events were discovered in CNVs
with copy-number decreases. Twelve downregulations
(lower copy number and lower expression) were found
forPS3andCS,whereasonlyfourupregulatedCNVs(higher
expression) were found for PS3 and CS. It appears that up-
and downregulated CNVs are positively associated with
gene copy-number changes.
Discussion
CNV Pattern in Homozygous Genotypes
Studies of copy-number variation in natural populations of
D. melanogaster had previously been conducted with het-
erozygous isofemale strains (Dopman and Hartl 2007;
Emerson et al. 2008). In these cases, many low-frequency
CNVs are heterozygous and may remain undetected. Here,
we established a number of second-chromosome substitu-
tion strains derived from a single Pennsylvania population
(except strain CS) to evaluate CNVoccurrence in completely
homozygousgenotypes.Theresultsindicateextensivecopy-
number variation on the second chromosome of these ﬂies.
Indeed, within the context of our own experimental design,
the fraction of protein-coding genes harboring CNVs that
can be detected in homozygotes is higher than that of het-
erozygotes. Furthermore, the faction of CNVs detected in
homozygous genotypes is also higher than that reported
in previous studies with heterozygous genotypes. These
FIG.6 . —Reconstruction of CNVs in heterozygotes and their effects
on gene expression. (A) As shown in ﬁgure 2, heterozygous PS2/PS3
expression can be compared with PS1/PS3 to infer CNVs’ dosage effects
on heterozygotes. The heterozygotes data were pooled from PS2/PS3
and PS2/CS together (for details, see Results) and plotted. The graph
shows the number of three groups of CNVs that are dosage sensitive,
dosage insensitive and dosage reversed. Het Ds: heterozygous dosage
sensitive; Het Di: heterozygous dosage insensitive; Het Dr: heterozygous
dosage reversed. (B) The fractions of dosage sensitive (gray), dosage
insensitive (black) and dosage reversed (white) for CNV increases and
decreases in heterozygotes are plotted separately.
FIG.7 . —The degree of protein interactions for CNV genes. (A) The
number of protein interactions for dosage-sensitive and dosage-
insensitive CNV genes is plotted. Dosage-sensitive genes have signiﬁ-
cantly more protein interactions. (B) The number of protein interactions
for recessive and nonrecessive CNV genes is plotted. Recessive genes
appear to have more protein interactions than nonrecessive genes.
However, the difference is not signiﬁcant. Bold horizontal bars are the
median value, the box is the interquartile range, and the whiskers
indicate the 95% conﬁdence interval.
FIG.8 . —Upregulated and downregulated CNVs are matched with
copy-number increase and decrease. As shown in ﬁgure 2, heterozy-
gous PS1/PS3 expression can be compared with homozygous PS1 to
infer if CNVs are upregulated or downregulated in heterozygotes (here,
PS3 contains CNVs). The black bars indicate the number of CNVs in
which PS3 (as well as CS, for details, see Results) CNV allele is
upregulated relative to PS1 in expression. The gray bars indicate
downregulation of PS3 (or CS) allele relative to PS1. The left two
columns show the CNVs with copy-number increases and the right two
columns show the CNVs with copy-number decreases.
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estimates CNVs in heterozygous genotypes because of a di-
minished power of detecting CNVs.
Also, previous studies found more duplications than de-
letions in fruit ﬂies (Emerson et al. 2008). One possibility is
that duplicating a region may confer milder phenotypes
than deleting it, such that purifying selection may be stron-
ger against deletions in CNV genes. Also, deletions in het-
erozygous state may potentially reduce the detection power
of CNVs in aCGH arrays. In another study examining mam-
malian genomes, the results suggested a strong bias against
duplications for genes whose protein products belong to
complexes, with less than a quarter of the CNVs scored
as gains (Schuster-Bo ¨ckler et al. 2010). In contrast, our
results found that the frequencies of copy-number increase
and decrease are exceptionally close in these substitution
lines, suggesting a highly variable CNV composition across
species and within species.
CNV Dosage Sensitivity and Effects on Expression
CNVs can have drastic phenotypic consequences as a result
ofalteringgenedosage,disruptingcodingsequences,orper-
turbing gene regulation. The degree of penetrance (the frac-
tion of a genotype that shows the associated phenotype) of
CNV encompassed genes is essential to understanding the
impact of CNVs on expression and potentially their associa-
tion with genetic disorders (Beckmann et al. 2007). We
found that 13% of homozygous CNVs were dosage sensi-
tive, meaning that gene expression levels positively associate
with copy-number increase or decrease. Conversely, we dis-
covered that 8% of CNVs were dosage reversed which ex-
hibited negative associations between expression and copy
number in homozygotes. The two categories were 9%
and 3%, respectively, for CNVs in heterozygous states.
Dosage-reversed CNVs were also discovered in human
genomes. In the case of copy-number duplications, 10%
of the CNVs in human genome were found to be dosage
reversed (Stranger et al. 2007; Beckmann et al. 2007).
Schuster-Bo ¨ckler et al. (2010) also reported a complex rela-
tionship between copy number and expression level in hu-
man heterozygous CNVs. For example, more than 10% of
the CNVs exhibited dosage-reversed expression pattern in
their study. In addition to genes exhibiting changes in both
copy number and expression, the remaining 79% of the
CNVs in homozygotes or 89% of the CNVs in heterozygotes
in our study were not responsive to gene copy-number
changes(dosageinsensitive).Similarly,around65%ofCNVs
were dosage insensitive in the studies conducted by Schus-
ter-Bo ¨ckler et al. (2010). All the above ﬁndings strongly sug-
gest an extremely complex relationship between gene copy
number and expression.
Young duplicated genes typically exhibit increased expres-
sion divergence (Farre and Alba 2010). Under certain condi-
tions, gene duplications may induce reduced transcripts or
even gene silencing. On the contrary, deletion of a transcrip-
tional repressor could serve to elevate gene expression
(Stranger et al. 2007). Both factors could contribute to the
discoveryofCNVs whose expression phenotypeisdosagere-
versed. On the other hand, dosage-insensitive CNVs could
ariseifgenepromoterregionswerenotduplicatedordeleted
along with the CNV regions. Also partial duplication or de-
letion of genes may not signiﬁcantly affect gene expression
levels. Nevertheless, the presence of detectable gene expres-
sion implies that at least one copy of the gene is present.
Therefore, a deletion occurred in one of the other copy or
copies did not signiﬁcantly change the expression.
CNVs can alter gene doses without abolishing gene func-
tion or changing phenotype. As shown in the results, the
majority of CNVs were found to be dosage insensitive, par-
ticularly in heterozygous CNVs. Therefore, CNVs appear to
be less likely to contain dosage-sensitive genes, indicating
that negative selection acts on the shaping of CNVs. Previ-
ously, CNV genes encoding protein complexes were found
to be signiﬁcantly underrepresented (Dopman and Hartl
2007; Schuster-Bo ¨ckler et al. 2010). Hence, selection facil-
itates the formation and spread of CNV patterns due to
functional constraints.
The observations between low or no change in gene ex-
pression andchangeofgenecopy number suggestthatcells
may attempt to compensate changes in gene copy number
on expression by modifying transcription. Dosage compen-
sation has been widely addressed in plants, worms, mam-
mals, and fruit ﬂies (Charlesworth 1996; Birchler et al.
2005, 2007; Vicoso and Bachtrog 2009; Prestel et al.
2010). The molecular mechanism of dosage compensation
involves chromatin structure remodeling (Bachtrog et al.
2010; Prestel et al. 2010). Transcription factors, chromatin
proteins, and signal-transduction genes were found to be
predominantly responsible for dosage effects (Birchler
et al. 2001, 2005). However, the mechanisms by which
CNVs affect dosage compensation are not well understood.
CNVs dosage effects on gene expression may be dependent
on local chromatin modiﬁcations or regulatory genes in the
dosage compensation cascades. Note that some CNVs
change dosage status from homozygotes to heterozygotes
(e.g.,dosage-sensitiveCNVs inhomozygotes becomeinsen-
sitive or vice versa), again suggesting a complex relationship
between gene dosage and expression.
CNVs are Largely Recessive in Heterozygous State
Previous studies reported that 70% of differentially ex-
pressed genes in homozygotes were masked in heterozy-
gous state (Lemos et al. 2008). CNVs encompassed genes
appeared to show similar patterns in our studies. More than
70% of the CNVs that were sensitive to copy-number
changes in contrasts between homozygous individuals
Zhou et al. GBE
1022 Genome Biol. Evol. 3:1014–1024. doi:10.1093/gbe/evr023appeared toberecessive when in the heterozygote (ﬁg. 5A).
This ﬁnding suggests a buffered response to structural
changes induced by CNVs and implies that heterozygous
masking effect may protect genes fromharmful consequen-
ces. In the case of gene duplications, apparent masking in
heterozygotesmayreﬂectthereducedpowertodetecttran-
script abundances of 3:2 in heterozygotes versus 4:2 in ho-
mozygotes. Silencing by unpaired DNA might be another
mechanism operating in heterozygous CNVs (Shiu and Met-
zenberg 2002). The unpaired copy of a gene might reduce
the expression of other homozygous copies in the genome.
Consistent with a previous report (Dopman and Hartl
2007), we found that only 20% of the CNVs were nonsin-
gletons in the population. Interestingly, the fraction of non-
singletons for recessive dosage-sensitive CNVs is increased
signiﬁcantly (47%) compared with that of overall CNVs
(ﬁg. 5B). The increase suggests that selection typically pre-
vents the spread of CNVs in natural populations, however,
with a higher tolerance if the CNVs are recessive in their ef-
fects on expression. Consistent with this hypothesis, the
fractions of singletons and nonsingletons for nonrecessive
dosage-sensitive CNVs did not differ from that of overall
CNVs (ﬁg. 5B). Another category in which the fraction of
nonsingleton increased signiﬁcantly consists of dosage-
insensitive CNVs, most likely due to the low penetrance
of CNVs having little or no effects on phenotypes.
Selection May Constrain Protein Interactions for
CNV Genes
It is known that protein-coding changes may impair the abil-
ity of a protein to form dependable network interactions
(Fraser et al. 2002). CNVs were reported to negatively cor-
relate with the degree of protein interaction network
(Dopman and Hartl 2007), indicating selection is likely to
shape the CNV distribution. Here, we also found that dos-
age-sensitive CNVs have fewer protein–protein interactions
than dosage-insensitive CNVs (ﬁg. 7A). Dosage-insensitive
genes are less stringent to structural changes such that their
mutational inﬂuences in the protein network are kept min-
imal. In contrast, stronger selection on central nodes may
result in dosage-sensitive genes showing a lessened number
of protein–protein interactions and betweenness. Similarly,
recessive CNV genes were expected to have more protein
interactions than nonrecessive ones. However, possibly
due to a relatively small sample size, they did not show sta-
tistically signiﬁcant difference in our study although the
trend appeared consistent with the expectation (ﬁg. 7B).
Up- and Downregulated CNVs Coincide with Copy-
Number Increase and Decrease
CNVs that are upregulated or downregulated in expression
were found positively associated with their copy-number
changes (ﬁg. 8). The fraction of upregulated or downregu-
lated CNVs is higher than that of dosage-sensitive CNVs in
heterozygotes discussed above (;27% vs. ;10%). Some
trans-effects (or background effects from PS3) may be in-
volved in determining dosage effects in heterozygotes. In
the case of up- and downregulated CNVs (ﬁg. 8), one
may expect that the fraction of singletons would increase
relative to that of overall CNVs because selection is presum-
ably against gene copy-numberchanges. However, the frac-
tion of singletons and nonsingletons did not differ from that
of overall CNVs (data not shown).
Conclusions
This study has revealed several important features of CNVs
in a number of second-chromosome substitution lines from
a single natural population of D. melanogaster, particularly
with respect to the balance between CNV encompassed
gene dosage and expression. The fraction of CNVs among
homozygotes appeared to be higher than in heterozygotes,
indicatingunderestimationbyaCGHarrays.Wefoundmany
cases of CNV genes that are sensitive to copy-number
changes. However, the majority of genes show no signiﬁ-
cant change in expression with copy number. More than
70% of the CNVs are recessive in expression in heterozy-
gotes. Selection appears to prevent CNVs from spreading
in the population as indicated by allele frequencies, recessive
CNVs, and protein interaction data. With this CNV and ex-
pression association study in D. melanogaster, we have
achieved an understanding of CNV dosage effect to some
extent. Many questions still remain unsolved such as CNV
distributions on other chromosomes besides the second,
what mechanisms cells employ to modulate CNV dosage
andreachabalance.DespitethecriticalroleofCNVsinshap-
inggenotypes andphenotypes, the majority of theidentiﬁed
CNVs have not yet been ﬁnely resolved to the nucleotide
level. Large CNV genotype data sets from different popula-
tions are required to extensively study the roles of CNV in
genome evolution. Next-generation sequencing or a combi-
nation of aCGH array and sequencing tools will enable us to
dissect this relationship further to greater resolution.
Supplementary Material
Supplementary ﬁgures S1–S3 and table S1 are available at
Genome Biology and Evolution online (http://www.
oxfordjournals.org/our_journals/gbe).
CNVraw data reported in this paper have been deposited
in the Gene Expression Omnibus (GEO) database,
www.ncbi.nlm.nih.gov/geo (accession no. GSE27632).
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